Press centre

Joint press release

Better bednets provide new hope in reducing malaria

A billion dollars to pay for more effective interventions

ARUSHA, TANZANIA, 17 November 2004 – New technologies for malaria prevention and treatment, combined with an increase in available funding, are fuelling optimism in the fight against malaria.  Global leaders gathered in Arusha for the launch of A to Z Textiles—the first factory in Africa to produce long-lasting insecticidal mosquito nets—agreed that conditions were right for a massive scale-up in the battle against the disease, which claims more than a million lives each year and hampers development, especially in Africa.

"Long-lasting insecticidal nets are Africa's best hope for preventing malaria, and we are very proud that Tanzania is the home of Africa's first manufacturer of these nets," said the President of the United Republic of Tanzania, Benjamin W. Mkapa.  "We hope that this shining example of technology transfer and strengthening of local industry will serve as a model for similar efforts, making the nets more affordable and available to the millions of Africans who need them."

President Mkapa, delivered a message of hope to a group of dignitaries including US Secretary of Health and Human Services Tommy Thompson, Roll Back Malaria Partnership Executive Secretary Awa Marie Coll-Seck, and Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Richard Feachem, as well as representatives of the Roll Back Malaria partners who had made the A to Z  technology transfer possible.

The technology for long-lasting insecticidal nets, which embed insecticide within the net’s very fibres and therefore retain their efficacy for up to five years without retreatment, was transferred to Tanzania last year in a groundbreaking collaboration between private and public sector players including the Acumen Fund, Sumitomo Chemical, the World Health Organization, UNICEF, ExxonMobil, and Population Services International.  A to Z Textiles now produces nearly half a million of these new nets each year and hopes to ramp up production to pass the one-million mark in 2005.

Additionally, the latest generation of highly effective malaria treatments known as artemisinin-based combination therapy (ACT) offer a cure that so far has met only minimal resistance from the malaria parasite.  Derived from the Artemisia annua (sweet wormwood) plant traditionally used to treat malaria in China, these medicines have become the drug of choice for more than 40 countries (20 of them in Africa), and demand for them has increased rapidly.

The factory visit took place in the context of the 9th board meeting of the Global Fund, which is being held in Arusha from 17-19 November.  “The Global Fund has committed nearly $1 billion over the coming two years and expects to scale up malaria funding substantially,” said Global Fund Executive Director Feachem.  "These funds will be used by countries to purchase both preventive and curative tools—including long-lasting nets, artemisinin-based combination therapy, and insecticide spraying where suitable—for maximum impact against malaria."  The Global Fund is also working with Roll Back Malaria partners to provide the financial incentives that will bring a new malaria vaccine to the market.

"This is a new era for malaria control," declared the Roll Back Malaria Partnership's Coll-Seck.  "Demand for this latest generation of effective malaria-control tools is increasing rapidly, and so is funding.  If we can replicate the success of A to Z to ensure an adequate supply of long-lasting insecticidal nets, and work with pharmaceutical companies to ensure ACT supplies, we will demonstrate the true power of public-private partnerships by dramatically reducing malaria deaths."
 

For more information, please contact:

RBM Partnership Secretariat
Pru Smith  +41 79 477 1744
Lauren Ptito Anderson   +41 22 791 2167

The Global Fund to Fight AIDS, Tuberculosis and Malaria
Jon Lidén  +41 79 244 6006
Patrick Bertrand   +33 6 60 04 04 42
Lyndon Barends   +27 8 29901057
Jim Palmer   +1 202 262 9823

A to Z Textile Mills Limited
Binesh Haria  + 255 27 2548888 / 2548895 / 2508139, azpfl@habari.co.tz

Acumen Fund
Gavin White   +1 212 566 8821 ext. 106, gwhite@acumenfund.org 

ExxonMobil
Didier Lutsen  + 32 2 722 44 87, didier.lutsen@exxonmobil.com

UNICEF
Victor Chinyama  +254-20-622218 (office), +254-722-701505 (mobile), vchinyama@unicef.org

WHO
Judith Mandelbaum-Schmid  +41 22 791 2967

PSI
Jane E. Miller  +255 744 572 611, jem@psi.or.tz


 

 

 

 Email this article

 Printer friendly

 Press Releases

New enhanced search